share_log

PharmaCyte Biotech | SC 13G: Statement of acquisition of beneficial ownership by individuals-Ayrton Capital LLC(9.99%),Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B(9.99%), etc.

SEC announcement ·  May 19, 2023 17:19
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more